Authors:
Davis, C
Heredia, A
Le, N
Dominique, JK
Redfield, RR
Citation: C. Davis et al., Differential human immunodeficiency virus-suppressive activity of reverse transcription inhibitors in resting and activated peripheral blood lymphocytes - Implications for therapy, J HUMAN VIR, 4(3), 2001, pp. 113-122
Authors:
Nagarajan, R
Svaren, J
Le, N
Araki, T
Watson, M
Milbrandt, J
Citation: R. Nagarajan et al., EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression, NEURON, 30(2), 2001, pp. 355-368
Citation: Ss. Djokic et al., An electrochemical analysis of thin silver films produced by reactive sputtering, J ELCHEM SO, 148(3), 2001, pp. C191-C196
Authors:
Nolte, LA
Yarasheski, KE
Kawanaka, K
Fisher, J
Le, N
Holloszy, JO
Citation: La. Nolte et al., The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle, DIABETES, 50(6), 2001, pp. 1397-1401
Citation: U. Spohr et al., The syntheses of 6-C-alkyl derivatives of methyl alpha-isomaltoside for a study of the mechanism of hydrolysis by amyloglucosidase, CAN J CHEM, 79(2), 2001, pp. 238-255
Authors:
Heredia, A
Margolis, D
Oldach, D
Hazen, R
Le, N
Redfield, R
Citation: A. Heredia et al., Abacavir in combination with the inosine monophosphate dehydrogenase (IMPDH)-inhibitor mycophenolic acid is active against multidrug-resistant HIV-1 (vol 22, pg 406, 1999), J ACQ IMM D, 23(1), 2000, pp. 105-105
Authors:
Kobayashi, H
Kao, CHK
Kreitman, RJ
Le, N
Kim, MK
Brechbiel, MW
Paik, CH
Pastan, I
Carrasquillo, JA
Citation: H. Kobayashi et al., Pharmacokinetics of In-111- and I-125-labeled antiTac single-chain Fv recombinant immunotoxin, J NUCL MED, 41(4), 2000, pp. 755-762
Authors:
Sun, BF
Kobayashi, H
Le, N
Yoo, TM
Drumm, D
Paik, CH
McAfee, JG
Carrasquillo, JA
Citation: Bf. Sun et al., Effects of insulinlike growth factor binding proteins on insulinlike growth factor-I biodistribution in tumor-bearing nude mice, J NUCL MED, 41(2), 2000, pp. 318-326
Authors:
Epstein, JB
Gorsky, M
Guglietta, A
Le, N
Sonis, ST
Citation: Jb. Epstein et al., The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy, CANCER, 89(11), 2000, pp. 2258-2265
Authors:
Heredia, A
Margolis, D
Oldach, D
Hazen, R
Le, N
Redfield, R
Citation: A. Heredia et al., Abacavir in combination with the inosine monophosphate dehydrogenase (IMPDH)-inhibitor mycophenolic acid is active against multidrug-resistant HIV-1, J ACQ IMM D, 22(4), 1999, pp. 406-407
Authors:
Epstein, JB
Emerton, S
Lunn, R
Le, N
Wong, FLW
Citation: Jb. Epstein et al., Pretreatment assessment and dental management of patients with nasopharyngeal carcinoma, ORAL ONCOL, 35(1), 1999, pp. 33-39
Authors:
Kobayashi, H
Tagaya, Y
Han, ES
Kim, IS
Le, N
Paik, CH
Pastan, I
Nelson, DL
Waldmann, TA
Carrasquillo, JA
Citation: H. Kobayashi et al., Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin 2, CYTOKINE, 11(12), 1999, pp. 1065-1075
Authors:
Kim, IS
Yoo, TM
Kobayashi, H
Kim, M
Le, N
Wang, Q
Pastan, I
Carrasquillo, JA
Paik, CH
Citation: Is. Kim et al., Chemical modification to reduce renal uptake of disulfide-bonded variable region fragment of anti-Tac monoclonal antibody labeled with Tc-99m, BIOCONJ CHE, 10(3), 1999, pp. 447-453
Authors:
Kim, MK
Seidel, J
Le, N
Kim, IS
Yoo, TM
Barker, C
Kobayashi, H
Green, MV
Carrasquillo, JA
Paik, CH
Citation: Mk. Kim et al., Evaluation of Tc-99m-mercaptoacetyltriglycine-biocytin as a new hepatobiliary imaging agent in mice coinjected with bilirubin, NUCL MED BI, 26(1), 1999, pp. 43-49
Authors:
Shariff, S
Yoshida, EM
Gascoyne, RD
Le, N
Connors, JM
Middleton, PJ
Shenkier, TN
Citation: S. Shariff et al., Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: A cross-sectional analysis, ANN ONCOL, 10(8), 1999, pp. 961-964
Authors:
Au, WY
Gascoyne, RD
Le, N
Viswanatha, DS
Klasa, RJ
Gallagher, R
Connors, JM
Citation: Wy. Au et al., Incidence of second neoplasms in patients with MALT lymphoma: No increase in risk above the background population, ANN ONCOL, 10(3), 1999, pp. 317-321
Authors:
Kobayashi, H
Sun, BF
Yoo, TM
Le, N
Kim, MK
Paik, CH
Pastan, I
Waldmann, TA
Carrasquillo, JA
Citation: H. Kobayashi et al., Methods to avoid adverse effect of circulating antigen on biodistribution of I-125-labeled antiTac dsFv: Preinjection of intact antibody versus clearance of antigen with avidin-biotin system, J NUCL MED, 40(8), 1999, pp. 1381-1391
Authors:
Kobayashi, H
Kim, IS
Drumm, D
Kim, MK
Paik, DS
Le, N
Waldmann, TA
Carrasquillo, JA
Paik, CH
Citation: H. Kobayashi et al., Favorable effects of glycolate conjugation on the biodistribution of humanized antiTac Fab fragment, J NUCL MED, 40(5), 1999, pp. 837-845
Authors:
Carrasquillo, JA
White, JD
Paik, CH
Raubitschek, A
Le, N
Rotman, M
Brechbiel, MW
Gansow, OA
Top, LE
Perentesis, P
Reynolds, JC
Nelson, DL
Waldmann, TA
Citation: Ja. Carrasquillo et al., Similarities and differences in In-111- and Y-90-labeled 1B4M-DTPA antiTacmonoclonal antibody distribution, J NUCL MED, 40(2), 1999, pp. 268-276
Authors:
Kobayashi, H
Le, N
Kim, IS
Kim, MG
Pie, JE
Drumm, D
Paik, DS
Waldmann, TA
Paik, CH
Carrasquillo, JA
Citation: H. Kobayashi et al., The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points, CANCER RES, 59(2), 1999, pp. 422-430